International Partnership For Microbicides

What International Partnership For Microbicides does

The International Partnership for Microbicides (IPM) is a non-profit product development partnership founded in 2002 and headquartered in Silver Spring, Maryland, with 101–250 employees. The organization is dedicated to preventing HIV transmission by accelerating the development and global availability of microbicide-based prevention products. Its intended end-users are women and other at-risk populations in low- and middle-income countries where HIV incidence remains high and where woman-controlled prevention methods address a critical unmet need.

IPM's core activity is pharmaceutical R&D: advancing microbicide candidates through preclinical and clinical development toward regulatory approval, then supporting access and distribution in HIV-endemic regions through partnerships with public-sector and NGO buyers. The organization does not sell products commercially; its business model is grant-funded, with philanthropic and government donor capital underwriting the R&D pipeline and downstream access partnerships. The company's accumulated know-how includes proprietary microbicide formulation and clinical-trial expertise built over two decades of operation.

A defining structural feature of IPM is its near-total reliance on donor funding. A $60 million grant from the Bill & Melinda Gates Foundation in April 2003 was the founding capital injection that established IPM's R&D scale, and the organization has operated at a sustained 100–250-person headcount band. Founder and CEO Zeda Rosenberg and Director Mark Mitchnick constitute the core executive leadership, and the organization has maintained this lean governance configuration since inception.

Name

International Partnership For Microbicides

Legal name

The Population Council, Inc.

Website

https://ipmglobal.org

Company type

Private

Founded year

1952

Operating status

Operating

Headcount range

101–250 employees

Short description

The International Partnership for Microbicides (IPM) is a non-profit founded in 2002 in Silver Spring, Maryland, that develops microbicide-based HIV prevention products for women and at-risk populations in low- and middle-income countries through grant-funded R&D and global access partnerships.

Ownership category

akta.pro rank

Headquarters

HQ city

Silver Spring

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Others

Distribution channels2 records

Marketing channels3 records

Core offering

International Partnership For Microbicides (IPM) is a nonprofit product development partnership that accelerates the development and availability of HIV prevention products, with a primary focus on microbicides and other woman-initiated biomedical prevention technologies for women in low- and middle-income countries. Founded in 2002 and headquartered in Silver Spring, Maryland, IPM conducts preclinical research, clinical development, regulatory engagement, and manufacturing scale-up to deliver affordable HIV prevention products through public-sector and global health channels.

Differentiator

Problem solved

Functional benefit

Brands

• Population and Development Review Journal: A peer-reviewed academic journal published by the Population Council covering population and development topics.
• Studies in Family Planning Journal

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Broad incumbents

• Elizabeth Glaser Pediatric AIDS Foundation: Major HIV-focused nonprofit working on prevention, treatment, and advocacy, with substantial donor-funded program operations in LMICs. Comparable to IPM in funding model and global footprint, though broader in mandate.
• PATH: Large global health innovation nonprofit working across vaccines, diagnostics, and reproductive health. Comparable as a science-to-access intermediary with a similar portfolio of foundation-funded programs and LMIC rollout capabilities.
• amfAR (Foundation for AIDS Research): Large, established HIV research funder with a broad portfolio across treatment, prevention, and cure. Comparable to IPM in HIV-prevention mission but operates at a wider scope and scale rather than narrow microbicide specialization.
• FHI 360: Large international NGO delivering global health and development programs, including HIV prevention research. Comparable to IPM in global health mandate and funder mix, with a far broader service portfolio.

Direct peers

• AVAC (Global Advocacy for HIV Prevention): Global nonprofit working exclusively on HIV prevention research advocacy and rollout. Highly comparable to IPM given the shared HIV-prevention mandate, donor-funded model, and focus on accelerating access to under-deployed prevention products.
• TB Alliance: Nonprofit product-development partnership advancing novel TB regimens with foundation/government support. Highly comparable organizational structure to IPM as a mission-driven PDP.
• Medicines for Malaria Venture (MMV): Product-development partnership funded largely by foundations to accelerate novel antimalarials. Directly comparable to IPM as a single-disease PDP with foundation anchor funding and a focus on access in LMIC markets.
• CONRAD (Eastern Virginia Medical School): Research organization developing HIV/STI prevention products including microbicides and multipurpose prevention technologies. Overlaps tightly with IPM's microbicide development focus.
• International AIDS Vaccine Initiative (IAVI): Product-development partnership funded by major foundations to accelerate HIV prevention science. Directly comparable to IPM as a science-led, funder-dependent nonprofit pushing a specific HIV-prevention modality through late-stage research.

Emerging players

• Microbicide Trials Network (MTN): NIH-funded clinical trials network conducting pivotal microbicide and PrEP studies. Comparable to IPM as a microbicide-development entity, but operating as a research network rather than a product development organization.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/ipmicrobicides
• LinkedInlinkedin.com/company/international-partnership-for-microbicides
• Facebookfacebook.com/internationalpartnershipformicrobicides

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Partnership For Microbicides